Reports

The global Genome Editing Tool Enzymes market was valued at 415 million in 2025 and is projected to reach US$ 600 million by 2032, at a CAGR of 5.5% during the forecast period.

The global DNA Editing Enzymes market was valued at 415 million in 2025 and is projected to reach US$ 600 million by 2032, at a CAGR of 5.5% during the forecast period.

The global DNA Editing Tool Enzymes market was valued at 415 million in 2025 and is projected to reach US$ 600 million by 2032, at a CAGR of 5.5% during the forecast period.

The global Genome Cutting Enzymes market was valued at 415 million in 2025 and is projected to reach US$ 600 million by 2032, at a CAGR of 5.5% during the forecast period.

The global Targeted Alpha-particle Therapy market was valued at 1084 million in 2025 and is projected to reach US$ 3855 million by 2032, at a CAGR of 20.1% during the forecast period.

The global Genome Editing Enzymes market was valued at 415 million in 2025 and is projected to reach US$ 600 million by 2032, at a CAGR of 5.5% during the forecast period.

The global Organ-On-Chips (OOC) market was valued at 201 million in 2025 and is projected to reach US$ 1383 million by 2032, at a CAGR of 32.5% during the forecast period.

The global Low-Density Lipoprotein (LDL) Cholesterol Test market was valued at 3881 million in 2025 and is projected to reach US$ 5919 million by 2032, at a CAGR of 6.3% during the forecast period.

The global Children Genetic Disease Diagnosis market was valued at 4452 million in 2025 and is projected to reach US$ 8080 million by 2032, at a CAGR of 9.0% during the forecast period.

The global HLA-Homozygous iPSC Cell Bank market was valued at 58.44 million in 2025 and is projected to reach US$ 307 million by 2032, at a CAGR of 26.5% during the forecast period.